(Q64446805)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733432%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Endothelins are potent vasoconstrictors, and much more besides (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733432%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733432%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

B Battistini

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733432%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D J Webb

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733432%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733432%20AND%20SRC:MED&resulttype=core&format=json

Trends in Pharmacological Sciences

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733432%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733432%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733432%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

38-40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733432%20AND%20SRC:MED&resulttype=core&format=json

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901431-5

7 January 2021

The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901431-5

7 January 2021

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901431-5

7 January 2021

Isoforms of endothelin-converting enzyme: why and where?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901431-5

7 January 2021

Transgenic expression of the endothelin-B receptor prevents congenital intestinal aganglionosis in a rat model of Hirschsprung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901431-5

7 January 2021

Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901431-5

7 January 2021

The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901431-5

7 January 2021

10.1016/S0165-6147(99)01431-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733432%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference